Wei-Ye Deng

Wei-Ye Deng

UNVERIFIED PROFILE

Are you Wei-Ye Deng?   Register this Author

Register author
Wei-Ye Deng

Wei-Ye Deng

Publications by authors named "Wei-Ye Deng"

Are you Wei-Ye Deng?   Register this Author

4Publications

38Reads

45Profile Views

FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.

Cell Death Dis 2019 May 1;10(5):356. Epub 2019 May 1.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-019-1574-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494834PMC
May 2019

CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.

BMC Cancer 2018 May 2;18(1):514. Epub 2018 May 2.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, Guangdong, 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4249-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932876PMC
May 2018

Notch-1 and Ki-67 receptor as predictors for the recurrence and prognosis of Kimura's disease.

Int J Clin Exp Pathol 2014 15;7(5):2402-10. Epub 2014 Apr 15.

Department of Head and Neck Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine 651 Dongfeng East Road, Guangzhou City, Guangdong Province, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069944PMC
February 2015

[Fine-needle aspiration with measurement of parathyroid hormone levels in thyroidectomy].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2013 Nov;48(11):934-8

Department of Head and Neck Surgery, SUN Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China. Email:

View Article

Download full-text PDF

Source
November 2013